Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2014

01-02-2014 | Endocrine Imaging

A rare case of small cell neuroendocrine carcinoma of the urinary bladder incidentally detected by F-18-FDG PET/CT

Authors: Giorgio Treglia, Massimo Bongiovanni, Luca Giovanella

Published in: Endocrine | Issue 1/2014

Login to get access

Excerpt

A 70-year-old female patient with history of endometrial carcinoma (successfully treated with hysterectomy and radiotherapy 3 years ago) underwent Fluorine-18-Fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) for restaging due to increasing serum tumor markers levels. At the time of F-18-FDG PET/CT scan, the patient presented dysuria. …
Literature
1.
S. Howard, K. O’Regan, J. Jagannathan, K. Krajewski, A. Giardino, N. Ramaiya, Extrapulmonary small cell carcinoma: a pictorial review. AJR Am. J. Roentgenol. 197, W392–W398 (2011)PubMedCrossRef
2.
X. Zhao, E.A. Flynn, Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy. Arch. Pathol. Lab. Med. 136, 1451–1459 (2012)PubMedCrossRef
3.
S. Thota, G. Kistangari, H. Daw, T. Spiro, A clinical review of small-cell carcinoma of the urinary bladder. Clin Genitourin Cancer 11, 73–77 (2013)PubMedCrossRef
Metadata
Title
A rare case of small cell neuroendocrine carcinoma of the urinary bladder incidentally detected by F-18-FDG PET/CT
Authors
Giorgio Treglia
Massimo Bongiovanni
Luca Giovanella
Publication date
01-02-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-9995-x

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue

Original Article

Gene polymorphisms and thyroid function in patients with heart failure

Original Article

Clinical presentation of Von Hippel Lindau syndrome type 2B associated with VHL p.A149S mutation in a large Turkish family

Review

Traumatic brain injury: endocrine consequences in children and adults

Erratum

Erratum to: Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves’ disease

Original Article

The effect of chronic kisspeptin administration on seminal fructose levels in male mice

Original Article

Adrenocortical reserves in hyperthyroidism
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits